A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with ...

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used ...

CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...

People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

A clinic in Arapahoe County is exploring new ways to help patients by offering ketamine-assisted psychotherapy.

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.

A new study has found small amounts of liquid ketamine administered in a clinical setting can significantly reduce symptoms ...

Spravato is now the first stand-alone therapy for treatment-resistant depression, for patients who haven't responded to oral ...